Gene Expression in Human Hippocampus from Cocaine Abusers Identifies Genes which Regulate Extracellular Matrix Remodeling

PLoS ONE

Volumn 2, Issue 11, 2007, Pages

  Mash, Deborah C ^a   Ffrench Mullen, Jarlath ^b   Adi, Nikhil ^a   Qin, Yujing ^a   Buck, Andrew ^a   Pablo, John ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Gene Logic Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; COCAINE DEPENDENCE; DNA MICROARRAY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; HUMAN; MALE; METABOLISM;

ADULT; COCAINE-RELATED DISORDERS; DOWN-REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 49849104302     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001187     Document Type: Article

References (64)

1. Hyman SE, Malenka RC, (2001) Addiction and the brain: The neurobiology of compulsion and it's persistance. Nature Rev. Neurosci 2: 695-703.
2. Everitt BJ, Wolf ME, (2002) Psychomotor stimulant addiction: A neural systems perspective. J Neurosci 22: 3312-3320.
3. Hernandez PJ, Kelley AE, (2005) Cracking addiction the second time around: reconsolidation of drug-related memories. Neuron 47: 772-775.
4. Whitlock JR, Heynen AJ, Shuler MG, Bear MF, (2006) Learning induces long-term potentiation in the hippocampus. Science 313: 1093-1097.
5. DiChiara G, Bassareo V, Fenu S, De Luca MA, Spina L, et al.(2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharm 47 S1: 227-241.
6. Goto Y, O'Donnell P, (2001) Synchronous activity in the hippocampus and nucleus accumbens in vivo. J Neurosci 21: RC131: 1-5.
7. Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL, (2001) Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 292: 1175-1178.
8. Thompson AM, Gosnell BA, Wagner JJ, (2002) Enhancement of long-term potentiation in the rat hippocampus following cocaine exposure. Neuropharm 42: 1039-1042.
9. Setler-Stevenson WG, (1996) Dynamics of matrix turnover during pathological remodelling of the extracellular matrix. Amer J Pathol 148: 1345-1350.
10. Woessner JF, (1994) The family of matrix metallopoteinases. Ann NY Acad Sci 732: 11-21.
11. Werb Z, (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439-432.
12. Stephens BG, Baselt R, Jentzen JM, Karch S, Mash DC, et al.(2004a) Criteria for the interpretation of cocaine levels in human biological samples and their relation to cause of death. J Forensic Med Path 25: 1-10.
13. Stephens BG, Jentzen JM, Karch S, Wetli CV, Mash DC, (2004b) National Association of Medical Examiners position paper on the certification of cocaine-related deaths. J Forensic Med Path 25: 11-13.
14. Corrado D, Basso C, Thiene G, (2001) Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50(2): 399-408.
15. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, et al.(2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Human Mol Gen 13(6): 609-16.
16. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P, (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: 53-67.
17. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, et al.(2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107(6): 789-800.
18. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, et al.(1998) Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Nat. Acad Sci USA 95: 13221-13226.
19. Lehrmann E, Oyler J, Vawter MP, Hyde TM, Kolachana B, et al.(2003) Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J 3: 27-40.
20. Koob GF, Sanna PP, Bloom FE, (1998) Neuroscience of addiction. Neuron 21: 467-476.
21. Nestler EJ, (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
22. Krasnova IN, Li SM, Wood WH, McCoy MT, Prabhu VV, et al.(2007) Transcriptional responses to reinforcing effects of cocaine in the rat hippocampus and cortex. Genes Brain Behav (Online Early Articles). doi:10.1111/j.1601-183X.2007.00338.x.
23. Sternlicht MD, Werb Z, (2001) How matrix metalloproteinases regulate cell behavior. Ann Rev Cell Dev Biol 17: 463-516.
24. Yong VW, Power C, Forsyth P, Edwards DR, (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2: 502-511.
25. Shapiro ML, Eichenbaum H, (1999) Hippocampus as a memory map: synaptic plasticity and memory encoding by hippocampal neurons. Hippocampus 9: 365-384.
26. Huntley GW, Benson DL, Colman DR, (2002) Structural remodeling of the synapse in response to physiological activity. Cell 108: 1-4.
27. Oray S, Majewska A, Sur M, (2004) Dendritic spine dynamics are regulated by monocular deprivation and extracellular matrix degradation. Neuron 44: 1021-1030.
28. Nagy V, Bozdagi O, Matynia A, Balcerzyk M, Okulski P, et al.(2006) Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 26: 1923-1934.
29. Bozdagi O, Nagy V, Kwei KT, Huntley GW, (2007) In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J Neurophysiol 98: 334-344.
30. Wang XQ, Sun P, Paller AS, (2003) Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin. J Biol Chem 278: 25591-25599.
31. Szklarczyk A, Lapinska J, Rylski M, McKay RD, Kaczmarek L, (2002) Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 22: 920-930.
32. Post RM, (2004) Neurobiology of seizures and behavioral abnormalities. Epilepsia 45 Suppl 2: 5-14.
33. Murase S, Mosser E, Schuman EM, (2002) Depolarization drives beta-catenin into neuronal spines promoting changes in synaptic structure and function. Neuron 35: 91-105.
34. Steinhausen U, Weiske J, Badock V, Tauber R, Bommert K, et al.(2001) Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 276: 4972-4980.
35. Fridman R, Toth M, Chvyrkova I, Meroueh SO, Mobashery S, (2003) Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 22: 153-166.
36. Lim S, Neisbitt S, Yoon J, Hwang JI, Suh PG, et al.(1999) Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J Biol Chem 274: 29510-29518.
37. Kramar ES, Bernard JA, Gall CM, Lynch G, (2003) Integrins modulate fast excitatory transmission at hippocampal synapses. J Biol Chem 278: 10722-10730.
38. Staubli U, Chun D, Lynch G, (1998) Time-dependent reversal of long-term potentiation by an integrin agonist. J Neurosci 18: 3460-3469.
39. Nakagami Y, Abe K, Nishiyama N, Matsuki N, (2000) Laminin degradation by plasmin regulates long-term potentiation. J Neurosci 20: 2003-2010.
40. Muraguchi T, Takegami Y, Ohtsuka T, Kitajima S, Chandana EPS, et al.(2007) RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity Nature Neurosci 10: 838-845.
41. Sasahara RM, Brochado SM, Takahashi C, Oh J, Maria-Engler SS, et al.(2002) Transcriptional control of the RECK metastasis/angiogenesis supressor gene. Cancer Det Prev 26: 435-443.
42. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, et al.(2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277: 36288-36295.
43. Erber R, Eichelsbacher U, Powaibo V, Korn T, Dionov V, et al.(2006) EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J 25: 628-641.
44. Magee JC, Carruth M, (1999) Dendritic voltage-gated ion channels regulate the action potential firing mode of hippocampal CA1 pyramidal neurons. J Neurophysiol 82: 1895-1901.
45. Fan Y, Fricker D, Brager DH, Chen X, Liu H-C, et al.(2005) Activity-dependent decrease of excitability in rat hippocampal neurons through increases in Ih. Nature Neurosci 8: 1542-1551.
46. Pape HC, (1996) Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Ann Rev Physiol 58: 299-327.
47. Van Welie I, van Hooft JA, Wadman WJ, (2004) Homeostatic scaling of neuronal excitability by synaptic modulation of somatic hyperpolarization-activated Ih channels. Proc Nat Acad Sci USA 101: 5123-5128.
48. Nolan MF, Malleret G, Dudman JT, Buhl DL, Santoro B, et al.(2004) A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons. Cell 119: 719-732.
49. Mellor J, Nicoll RA, Schmitz D, (2002) Mediation of hippocampal mossy fiber long-term potentiation by presynaptic Ih channels. Science 295: 143-147.
50. Smolen PD, Baxter DA, Byrne JH, (2006) A model of the roles of essential kinases in the induction and expression of late long-term potentiation. Biophys J 90: 2760-2775.
51. Johnston D, Christie BR, Frick A, Gray R, Hoffman DA, et al.(2003) Active dendrites, potassium channels and synaptic plasticity. Philos Trans R Soc Lond B Biol Sci 358 (1432): 667-674.
52. Neuhoff H, Neu A, Liss B, Roeper J, (2002) Ih channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci 22: 1290-1302.
53. Santoro B, Liu DT, Yao H, Bartsch D, Kandel ER, et al.(1998) Identification of a gene encoding a hyperpolarization-activated channel of brain. Cell 93: 717-729.
54. Chan CS, Shigemoto R, Mercer JN, Surmeier DJ, (2004) HCN2 and HCN1 channels govern the regularity of autonomous pacemaking and synaptic resetting in globus pallidus neurons. J Neurosci 24: 9921-9932.
55. Liu Q-R, Drgon T, Johnson C, Walther D, Hess J, Uhl GR, (2006) Addiction molecular genetics: 639,401 whole genome association identifies many 'cell adhesion' genes. Am J Med Genet B Neuropsych Genetics 141: 918-25.
56. Ishiguro H, Arai M, Uhl GR, (2007) Haplotypes for the drug-regulated cell adhesion molecule PTPRB are associated with addiction vulnerability. Addiction (In press).
57. Uhl G, Blum K, Noble E, Smith S, (1993) Substance abuse vulnerability and D2 receptor gene. Trends Neurosci 16: 83-8.
58. Noble EP, (2000) Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 15: 79-89.
59. Volkow ND, Fowler JS, Wang G-J, Swanson JM, (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psych 9: 557-569.
60. Sequeira A, Gwadry FG, ffrench-Mullen JM, Canetti L, Gingras Y, et al.(2006) Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psych 63: 35-48.
61. Sequeira A, Kemplan T, Canetti L, ffrench-Mullen J, Benkelfat C, et al.(2007) Patterns of gene expression in the limbic system of suicides with and without major depression. Mol. Psych 12: 640-655.
62. Papapetropoulos S, ffrench-Mullen J, McCorquodale D, Qin Y, Pablo J, et al.(2006) Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's Disease. Gene Expr 13: 205-215.
63. Lee HK, Braynen W, Keshav K, Pavlidis P, (2005) ErmineJ: tool for functional analysis of gene expression data sets. BMC Bioinformatics 6: 269.
64. Zhang JW, Gottschall PE, (1997) Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods 76: 15-20.